Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...